Journal of Substance Abuse Treatment

Article	Citations
Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine	97
Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19	90
A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder	87
Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic	83
A clash of epidemics: Impact of the COVID-19 pandemic response on opioid overdose	76
Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings	74
A systematic review of stigma interventions for providers who treat patients with substance use disorders	73
Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19	71
Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study	64
Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study	62
Peer recovery coaches in general medical settings: Changes in utilization, treatment engagement, and opioid use	50
Addressing racial & socioeconomic disparities in access to medications for opioid use disorder amid COVID-19	50
Experiences of racial discrimination in the medical setting and associations with medical mistrust and expectations of care among black patients seeking addiction treatment	47
Online digital recovery support services: An overview of the science and their potential to help individuals with substance use disorder during COVID-19 and beyond	46
COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns	46
Family involvement in treatment and recovery for substance use disorders among transition-age youth: Research bedrocks and opportunities	45
Telehealth sustains patient engagement in OUD treatment during COVID-19	43
Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island	43
Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19	42
The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19	42
Difficult binds: A systematic review of facilitators and barriers to treatment among mothers with substance use disorders	42
Impacts of COVID-19 on residential treatment programs for substance use disorder	42
Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms	41
Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?	39
Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis	38

Feasibility and early experience of a novel multidisciplinary alcohol-associated liver disease clinic	38
Adolescent substance use: Challenges and opportunities related to COVID-19	36
Increased flexibility in methadone take-home scheduling during the COVID-19 pandemic: Should this practice be incorporated into routine clinical care?	35
“A good mother”: Impact of motherhood identity on women's substance use and engagement in treatment across the lifespan	35
Rapid transitional response to the COVID-19 pandemic by opioid agonist treatment programs in Ukraine	34
“You have to take this medication, but then you get punished for taking it:” lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period	33
A scoping review of alcohol, tobacco, and other drug use treatment interventions for sexual and gender minority populations	33
COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings	33
A pilot randomized clinical trial of mindfulness-oriented recovery enhancement as an adjunct to methadone treatment for people with opioid use disorder and chronic pain: Impact on illicit drug use, he	32
Experiences of stigma in hospitals with addiction consultation services: A qualitative analysis of patients' and hospital-based providers' perspectives	32
The role of social network support in treatment outcomes for medication for opioid use disorder: A systematic review	32
Gender disparities in access and retention in outpatient methadone treatment for opioid use disorder in low-income urban communities	32
Digital delivery of a contingency management intervention for substance use disorder: A feasibility study with DynamiCare Health	32
Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic	31
Patterns of substance use before and after hospitalization among patients seen by an inpatient addiction consult service: A latent transition analysis	31
Experiences of stigma among individuals in recovery from opioid use disorder in a rural setting: A qualitative analysis	31
Adapting methadone inductions to the fentanyl era	29
“In their mind, they always felt less than”: The role of peers in shifting stigma as a barrier to opioid use disorder treatment retention	29
Mobile methadone medication units: A brief history, scoping review and research opportunity	28
Contingency management for treatment attendance: A meta-analysis	28
Low-barrier buprenorphine during the COVID-19 pandemic: A rapid transition to on-demand telemedicine with wide-ranging effects	27
Changes in methadone take-home dosing before and after COVID-19	27
Down the drain: Reconsidering routine urine drug testing during the COVID-19 pandemic	27
Racial/ethnic and gender differences in receipt of brief intervention among patients with unhealthy alcohol use in the U.S. Veterans Health Administration	27
Engaging the justice system to address the opioid crisis: The Justice Community Opioid Innovation Network (JCOIN)	26
The impact of COVID-19 on substance use disorder treatment in California: Service providers' perspectives	26
A feasibility study providing substance use treatment in the Black church	26
Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder	25
Patient-centered care's relationship with substance use disorder treatment utilization	25
A chance to do it better: Methadone maintenance treatment in the age of Covid-19	25
How emergency department visits for substance use disorders have evolved during the early COVID-19 pandemic	25
Drug and alcohol treatment utilization and barriers among Black, American Indian/Alaskan Native, Latine, Asian/Pacific Islander/Native Hawaiian, and White adults: Findings from NESARC-III	24
A smartphone-smartcard platform for contingency management in an inner-city substance use disorder outpatient program	24
Leveraging COVID-19 to sustain regulatory flexibility in the treatment of opioid use disorder	24
Adaptations to jail-based buprenorphine treatment during the COVID-19 pandemic	24
Massachusetts Justice Community Opioid Innovation Network (MassJCOIN)	23
Exploring first responders' perceptions of medication for addiction treatment: Does stigma influence attitudes?	23
Racial differences in overdose training, naloxone possession, and naloxone administration among clients and nonclients of a syringe services program	23
Substance use treatment in Appalachian Tennessee amid COVID-19: Challenges and preparing for the future	23
Peer recovery services for persons returning from prison: Pilot randomized clinical trial investigation of SUPPORT	22
The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use d	22
Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19	22
A systematic literature review of clinical trials and therapeutic applications of ibogaine	21
A collision of crises: Addressing an HIV outbreak among people who inject drugs in the midst of COVID-19	21
Real-world outcomes with extended-release buprenorphine (XR-BUP) in a low threshold bridge clinic: A retrospective case series	21
Legalization of cannabis use in Canada: Impacts on the cannabis use profiles of youth seeking services for substance use	21
Healthcare utilization patterns among persons who use drugs during the COVID-19 pandemic	21
The intersection of race and opioid use disorder treatment: A quantitative analysis	21
Integrated substance use and prenatal care delivery in the era of COVID-19	21
“No home to take methadone to”: Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston	21

Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada	21
Differential impacts of COVID-19 across racial-ethnic identities in persons with opioid use disorder	20
Racial/ethnic disparities in the availability of hospital based opioid use disorder treatment	20
Is necessity also the mother of implementation? COVID-19 and the implementation of evidence-based treatments for opioid use disorders	20
COVID-19 innovations in medication for addiction treatment at a Skid Row syringe exchange	20
With crisis comes opportunity: Unanticipated benefits resulting from pivots to take-home naloxone (THN) programs during the COVID-19 pandemic	19
Mobile low-threshold buprenorphine integrated with infectious disease services	19
Considering the harms of our habits: The reflexive urine drug screen in opioid use disorder treatment	19
COVID-19 and treating incarcerated populations for opioid use disorder	19
Leveraging digital tools to support recovery from substance use disorder during the COVID-19 pandemic response	19
The role of perceived treatment need in explaining racial/ethnic disparities in the use of substance abuse treatment services	18
“I have to be around people that are doing what I'm doing”: The importance of expanding the peer recovery coach role in treatment of opioid use disorder in the face of COVID-19 health disparities	18
Bridge clinic buprenorphine program decreases emergency department visits	18
Kentucky Women's Justice Community Opioid Innovation Network (JCOIN): A type 1 effectiveness-implementation hybrid trial to increase utilization of medications for opioid use disorder among justice-in	18
Providing addiction services during a pandemic: Lessons learned from COVID-19	18
Facilitators and barriers to post-overdose service delivery in Rhode Island emergency departments: A qualitative evaluation	18
Examining factors that shape use and access to diverted prescription opioids during an overdose crisis: A qualitative study in Vancouver, Canada	17
Revising our attitudes towards agonist medications and their diversion in a time of pandemic	17
Feasibility and acceptability of a digital health intervention to promote engagement in and adherence to medication for opioid use disorder	17
Assessing the determinants of completing OAT induction and long-term retention: A population-based study in British Columbia, Canada	17
Sharp decline in hospital and emergency department initiated buprenorphine for opioid use disorder during COVID-19 state of emergency in California	17
Mobile van delivery of extended-release buprenorphine and extended-release naltrexone for youth with OUD: An adaptation to the COVID-19 emergency	17
Research on substance use disorders during the COVID-19 pandemic	17
Telemedicine works for treating substance use disorder: The STAR clinic experience during COVID-19	17
Overdose deaths from nonprescribed prescription opioids, heroin, and other synthetic opioids in Medicare beneficiaries	17
Value of family involvement in substance use disorder treatment: Aligning clinical and financing priorities	17
Re-thinking patient stability for methadone in opioid treatment programs during a global pandemic: Provider perspectives	17
Recovering from substance use disorders during the early months of the COVID-19 pandemic: A mixed-methods longitudinal study of women in Kansas City	16
Unprecedented need and recommendations for harnessing data to guide future policy and practice for opioid use disorder treatment following COVID-19	16
Expanding buprenorphine treatment to people experiencing homelessness through a mobile, multidisciplinary program in an urban, underserved setting	16
A Facebook intervention to address cigarette smoking and heavy episodic drinking: A pilot randomized controlled trial	16
“They went down that road, and they get it”: A qualitative study of peer support worker roles within perinatal substance use programs	16
Health care-seeking experiences for people who inject drugs with hepatitis C: Qualitative explorations of stigma	16
Personal, provider and system level barriers and enablers for hepatitis C treatment in the era of direct-acting antivirals: Experiences of patients who inject drugs accessing treatment in general prac	16
Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults	16
Substance use among women who are pregnant: Examining treatment completion by race and ethnicity	16
Healthcare utilization of individuals with substance use disorders following Affordable Care Act implementation in a California healthcare system	15
Community coalition and key stakeholder perceptions of the community opioid epidemic before an intensive community-level intervention	15
Characterizing trends in methamphetamine-related health care use when there is no ICD code for “methamphetamine use disorder”	15
“Sick and tired of being sick and tired”: Exploring initiation of medications for opioid use disorder among people experiencing homelessness	15
It's not just the money: The role of treatment ideology in publicly funded substance use disorder treatment	15
Using machine learning to identify predictors of imminent drinking and create tailored messages for at-risk drinkers experiencing homelessness	15
Factors associated with psychotic symptoms among a sample of male prisoners with substance use disorder: A cross-sectional study	15
“If I had them, I would use them every time”: Perspectives on fentanyl test strip use from people who use drugs	15
Use of buprenorphine for those with employer-sponsored insurance during the initial phase of the COVID-19 pandemic	15
National trends in substance use treatment admissions for opioid use disorder among adults experiencing homelessness	15
Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse	15
Did drug use increase following COVID-19 relaxation of methadone take-out regulations? 2020 was a complicated year	15
Parent SMART (Substance Misuse in Adolescents in Residential Treatment): Pilot randomized trial of a technology-assisted parenting intervention	15
Increased availability of telehealth mental health and substance abuse treatment for peripartum and postpartum women: A unique opportunity to increase telehealth treatment	14
Long-acting depot buprenorphine in people who are homeless: Views and experiences	14
Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS)	14
Depot buprenorphine during COVID-19 in Australia: Opportunities and challenges	14
What is success in treatment for opioid use disorder? Perspectives of physicians and patients in primary care settings	14
Views of barriers and facilitators to continuing methadone treatment upon release from jail among people receiving patient navigation services	14
Traditions and Connections for Urban Native Americans (TACUNA): Utilizing community-based input to develop an opioid prevention intervention for urban American Indian/Alaska Native emerging adults	14
Augmenting substance use treatment in the drug court: A pilot randomized trial of peer recovery support	14
Treatment options and shared decision-making in the treatment of opioid use disorder: A scoping review	14
A pilot randomized clinical trial of Brief Behavioral Treatment for Insomnia to reduce problematic cannabis use among trauma-exposed young adults	14
Parental status and characteristics of women in substance use treatment services: Analysis of electronic patient records	14
Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic	14
A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail	14
The next wave? Mental health comorbidities and patients with substance use disorders in under-resourced and rural areas	14
Cannabis use disorder and post-traumatic stress disorder: The prevalence of comorbidity in veterans of recent conflicts	14
Use of an electronic pillbox to increase number of methadone take-home doses during the COVID-19 pandemic	14
Caring for women with substance use disorders through pregnancy and postpartum during the COVID-19 pandemic: Lessons learned from psychology trainees in an integrated OBGYN/substance use disorder outp	14
A qualitative analysis of barriers to opioid agonist treatment for racial/ethnic minoritized populations	13
Youth OUD treatment during and after COVID: Increasing family involvement across the services continuum	13
Drum-Assisted Recovery Therapy for Native Americans (DARTNA): Results from a feasibility randomized controlled trial	13
Competing risks of women and men who use fentanyl: “The number one thing I worry about would be my safety and number two would be overdose”	13
Predictors of engagement and retention in care at a low-threshold substance use disorder bridge clinic	13
Using structured implementation interventions to improve referral to substance use treatment among justice-involved youth: Findings from a multisite cluster randomized trial	13
Integrating harm reduction and clinical care: Lessons from Covid-19 respite and recuperation facilities	13
Is behavioral activation an effective and acceptable treatment for co-occurring depression and substance use disorders? A meta-analysis of randomized controlled trials	13
Beyond state scope of practice laws for advanced practitioners: Additional supervision requirements for buprenorphine prescribing	13
Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail	13
Improving retention across the OUD service cascade upon reentry from jail using Recovery Management Checkups-Adaptive (RMC-A) experiment	13
Extended-release naltrexone for youth with opioid use disorder	13
The COVID-19 pandemic and opioid use disorder: Expanding treatment with buprenorphine, and combining safety precautions with telehealth	13
Racial inequity in methadone dose at delivery in pregnant women with opioid use disorder	13

Developing a cascade of care for opioid use disorder among individuals in jail	12
Psychometric validation of an adaptation of the Penn Alcohol Craving Scale to assess aggregated drug craving	12
The principles and practices of psychoeducation with alcohol or other drug use disorders: A review and brief guide	12
Feasibility and acceptability of mindful recovery opioid use care continuum (M-ROCC): A concurrent mixed methods study	12
Treatment preference for opioid use disorder among people who are incarcerated	12
Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida	12
Increasing access to family planning services among women receiving medications for opioid use disorder: A pilot randomized trial examining a peer-led navigation intervention	12
Impact of COVID-19 on service delivery for an evidence-based behavioral treatment for families involved in the child welfare system	12
The impact of COVID-19 on opioid treatment program (OTP) services: Where do we go from here?	12
Use of non–prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarceration	12
Episodic future thinking for smoking cessation in individuals with substance use disorder: Treatment feasibility and acceptability	12
Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data	12
Race, ethnicity, and emergency department post-overdose care	12
Substance use predictors of attendance among veterans in integrated PTSD and alcohol use disorder treatment	12
Access to treatment for pregnant incarcerated people with opioid use disorder: Perspectives from community opioid treatment providers	12
Disease and decision	12
Virtual reality for behavioral health workforce development in the era of COVID-19	11
Attitudes toward opioid use disorder pharmacotherapy among recovery community center attendees	11
Exploring nonprescribed use of buprenorphine in the criminal justice system through qualitative interviews among individuals recently released from incarceration	11
A comparison of office-based buprenorphine treatment outcomes in Bronx community clinics before versus during the COVID-19 pandemic	11
Letting the sun shine on patient voices: Perspectives about medications for opioid use disorder in Florida	11
Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder	11
Reducing tobacco use in substance use treatment: An intervention to promote tobacco-free grounds	11
Recovery community centers: Characteristics of new attendees and longitudinal investigation of the predictors and effects of participation	11
Structural racism and reflections from Latinx heavy drinkers: Impact on mental health and alcohol use	11
Treatment admissions for opioids, cocaine, and methamphetamines among adolescents and emerging adults after legalization of recreational marijuana	11
“I didn't feel like a number”: The impact of nurse care managers on the provision of buprenorphine treatment in primary care settings	11
Adaptation of contingency management for stimulant use disorder during the COVID-19 pandemic	11
An efficacy trial of adaptive interventions for alcohol use disorder	11
A virtual reality study on postretrieval extinction of smoking memory reconsolidation in smokers	11
A scoping review of cultural adaptations of substance use disorder treatments across Latinx communities: Guidance for future research and practice	11
Sheltering in place and social distancing when the services provided are housing and social support: The COVID-19 health crisis and recovery housing	10
Impact of a computerized intervention for high distress intolerance on cannabis use outcomes: A randomized controlled trial	10
Nicotine and cannabis vaping among adolescents in treatment for substance use disorders	10
Utilization of substance use treatment among criminal justice-involved individuals in the United States	10
Emergency department–based efforts to offer medication treatment for opioid use disorder: What can we learn from current approaches?	10
The impact of race, gender, and heroin use on opioid addiction stigma	10
Using implementation interventions and peer recovery support to improve opioid treatment outcomes in community supervision: Protocol	10
Potential barriers to filling buprenorphine and naltrexone prescriptions among a retrospective cohort of individuals with opioid use disorder	10
Validity and measurement invariance of the Addictions Neuroclinical Assessment incentive salience domain among treatment-seekers with alcohol use disorder	10
Impact of a pharmacist-led substance use disorder transitions of care clinic on postdischarge medication treatment retention	10
Housing and supportive services for substance use and self-efficacy among young mothers experiencing homelessness: A randomized controlled trial	10
Predicting longitudinal service use for individuals with substance use disorders: A latent profile analysis	10
SMART Recovery International and COVID-19: Expanding the reach of mutual support through online groups	10
Barriers to retention in substance use treatment: Validation of a new, theory-based scale	10
Engagement patterns with a digital therapeutic for substance use disorders: Correlations with abstinence outcomes	10
National trends in buprenorphine prescribing before and during the COVID-19 pandemic	10
Precision dosing of methadone during pregnancy: A pharmacokinetics virtual clinical trials study	10
The new services that opioid treatment programs have adopted in response to COVID-19	10
Buprenorphine use and disparities in access among emergency department patients with opioid use disorder: A cross-sectional study	10
Suicidal behavior, opioid use disorder, and behavioral health treatment: Prevalence and correlates among adults in the United States 2015–2018	10
Simulating the experience of searching for LGBTQ-specific opioid use disorder treatment in the United States	9
Association between availability of medications for opioid use disorder in specialty treatment and use of medications among patients: A state-level trends analysis	9
Understanding the service needs of youth with opioid use: A descriptive study of demographics and co-occurring substance use and mental health concerns	9
Non–prescribed buprenorphine preceding treatment intake and clinical outcomes for opioid use disorder	9
Facilitating engagement of persons with opioid use disorder in treatment for hepatitis C virus infection via telemedicine: Stories of onsite case managers	9
The short-term effectiveness of real-time video counselling on smoking cessation among residents in rural and remote areas: An interim analysis of a randomised trial	9
Integrating substance use care into primary care for adolescents and young adults: Lessons learned	9
Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program	9
Evaluating disparities in prescribing of naloxone after emergency department treatment of opioid overdose	9
Public implementation of a web-based program for veterans with risky alcohol use and PTSD: A RE-AIM evaluation of VetChange	9
Scoping review of interventions to link individuals to substance use services at discharge from jail	9
Drug court utilization of medications for opioid use disorder in high opioid mortality communities	9
Treatment trajectories and barriers in opioid agonist therapy for people who inject drugs in rural Puerto Rico	9
A randomized comparison of 4 vs. 16 weeks of psychosocial treatment for stimulant users	9
The cascade of care for opioid use disorder among youth in British Columbia, 2018	9
Hepatitis C treatment outcomes among patients treated in co-located primary care and addiction treatment settings	9
Ethnic discrimination and alcohol-related problem severity among Hispanic/Latin drinkers: The role of social anxiety in the minority stress model	9
Brief training in regulation of craving reduces cigarette smoking	9
A mixed methods study exploring methadone treatment disclosure and perceptions of reproductive health care among women ages 18–44 years, Los Angeles, CA	9
The role of recovery housing during outpatient substance use treatment	9
Juvenile probation officers' perceptions on youth substance use varies from task-shifting to family-based contingency management	9
Same-day vs. delayed buprenorphine prescribing and patient retention in an office-based buprenorphine treatment program	8
Justice community opioid innovation network (JCOIN): The TCU research hub	8
Pre-exposure prophylaxis (PrEP) indication and uptake among people receiving buprenorphine for the treatment of opioid use disorder	8
Acceptability, feasibility, and outcomes of a clinical pilot program for video observation of methadone take-home dosing during the COVID-19 pandemic	8
A cohort study examining changes in treatment patterns for alcohol use disorder among commercially insured adults in the United States during the COVID-19 pandemic	8
Community perspectives on supervised consumption sites: Insights from four U.S. counties deeply affected by opioids	8
Stepped-wedge randomized controlled trial of a novel opioid court to improve identification of need and linkage to medications for opioid use disorder treatment for court-involved adults	8
A multi-methods and longitudinal study of patients' perceptions in injectable opioid agonist treatment: Implications for advancing patient-centered methodologies in substance use research	8
Trends in visits to substance use disorder treatment facilities in 2020	8
Consumer access to buprenorphine and methadone in certified community behavioral health centers: A secret shopper study	8
Emergency department interventions for opioid use disorder: A synthesis of emerging models	8
Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation	8
Substance use disorders among older populations: What role do race and ethnicity play in treatment and completion?	8
Baseline executive functions and receiving cognitive rehabilitation can predict treatment response in people with opioid use disorder	8
Associations of retention on buprenorphine for opioid use disorder with patient characteristics and models of care in the primary care setting	8
‘Not at all what I had expected’: Discontinuing treatment with extended-release naltrexone (XR-NTX): A qualitative study	8
The investigation of the mediating role of coping trategies on the relationship between childhood traumas, depression and alcohol use disorder in university students	8
Alliances to disseminate addiction prevention and treatment (ADAPT): A statewide learning health system to reduce substance use among justice-involved youth in rural communities	8
Reducing Opioid Mortality in Illinois (ROMI): A case management/peer recovery coaching critical time intervention clinical trial protocol	8
Correlates and predictors of suicidal ideation and substance use among adults seeking substance use treatment with varying levels of suicidality	8
A delicate compromise: Striking a balance between public safety measures and the psychosocial needs of staff and clients in residential substance use disorder treatment amid COVID-19	8
Tobacco use among substance use disorder (SUD) treatment staff is associated with tobacco-related services received by clients	8
Mobile technology and task shifting to improve access to alcohol treatment services in Mozambique	8